Though you may not realize it, more than 40,000 computer-brain interfaces have already been employed in healthcare today. Thus, to say computer-brain interfaces are something new would be inaccurate. But compared to what the future of neuromedicine holds, these types of interfaces are quite rudimentary. The real game-changer awaits us in the form of silicon brains and computer-brain connections. From neuromorphic computing to implanted brain chips, human—and machine—intelligence is about to take a quantum leap.
But at the same time, serious concerns exist. In addition to privacy and security risks, new problems could also arise from superintelligence. The question is how these advances in technology and science will be managed when it comes to being socially responsible.
Understanding Neuromorphic Computing and Brain Chips
At the current time, the two technologies of neuromorphic computing and brain chips are somewhat separated in terms of industries. Neuromorphic computing refers more to the pursuit of creating brain-like structures using silicon as a base. In these systems, individual silicon chips seek to function like individual brain neurons. Thus, ultimately, an actual silicon brain using neuromorphic computing would mimic a human’s brain functionally.
Brain chips, on the other hand, are being used to harness the power of the neuron in a single chip. But these pursuits are looking to use brain chips to foster connections to computing systems to improve human function. In doing so, human consciousness would have access to all the vast information and processing power available. Therefore, to say it in simple words, neuromorphic computing strives to give machines and robotics the power of the human brain. Meanwhile, brain chips seek to enhance human intelligence through connections to computing and information technologies.
Image Credit: Alias Studio
News This Week
The COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the infection process, as this knowledge is useful in designing vaccines and therapeutics. Now, a [...]
Scientists have developed protein fragments—called peptides—that fit snugly into a groove on the SARS-CoV-2 Spike protein that it would normally use to access a host cell. These peptides effectively trick the virus into "shaking hands" with a replica rather than with [...]
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology. T-cell immunity is one of [...]
When SARS-CoV-2 first began spreading across the globe, not every lab was equipped to study it directly. The virus behind the current pandemic is highly pathogenic and transmissible, leading the US Centers for Disease [...]
esearchers have detailed a mechanism in the distinctive corona of Covid-19 that could help scientists to rapidly find new treatments for the virus, and quickly test whether existing treatments are likely to work with [...]
Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health. Researchers from Bangladesh, the United States [...]
A team of investigators from the Republic of China has discovered that 6 drugs previously approved by the US Food and Drug Administration (FDA) for other indications could be repurposed to treat or prevent [...]
Graphene is a layer of carbon only one atom thick. Since it was first isolated in 2004, it has found applications in strengthening materials, accelerating electronics, and boosting performance in batteries, among others. It [...]
The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the approval of the first mRNA vaccines, which GlobalData expects will soon impact other indications. This historical landmark could have [...]
A single dose of the Pfizer coronavirus vaccine is “highly protective” after three weeks, according to a study. Researchers at the University of East Anglia (UEA) said the coronavirus vaccine developed by Pfizer and BioNTech was still effective [...]
Summary: Mice exposed to COVID-19 through the nasal passage, researchers noted a rapid and escalated attack on the brain by the virus that triggered a more severe outcome of the infection, even after the lungs [...]
GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they plan to work jointly to [...]
The great hope for drug treatments against Covid-19 – the monoclonal antibodies – are failing against variants of the virus, such as those that have emerged in South Africa and Brazil, scientists have found. [...]
Bandages are great for covering wounds, but they would be much more useful if they could also detect infections. By embedding nanosensors in the fibers of a bandage, University of Rhode Island Assistant Professor [...]